Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Junck

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
11C-DTBZ and 18F-FDG PET measures in differentiating dementiasRobert A Koeppe, Sid Gilman, Aniket Joshi, et al.
Sleep|October 13, 2005
Validation of a polysomnographic score for REM sleep behavior disorderFlavia B Consens, Ronald D Chervin, Robert A Koeppe, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive declineChristopher H Chapman, Vijaya Nagesh, Pia C Sundgren, et al.
Neuro-Oncology Practice|November 17, 2022
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphomaAnna M Laucis, Katherine Selwa, Yilun Sun, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2008
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiformeIrwin H Lee, Morand Piert, Diana Gomez-Hassan, et al.
Journal of Neuro-Oncology|September 18, 2008
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)Nicholas Butowski, Susan M Chang, Larry Junck, et al.
Scientific Reports|November 24, 2020
Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learningJoonsang Lee, Nicholas Wang, Sevcan Turk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastomaChristina I Tsien, Doris Brown, Daniel Normolle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade gliomaChristina Tsien, Craig J Galbán, Thomas L Chenevert, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
11C-DTBZ and 18F-FDG PET measures in differentiating dementiasRobert A Koeppe, Sid Gilman, Aniket Joshi, et al.
Sleep|October 13, 2005
Validation of a polysomnographic score for REM sleep behavior disorderFlavia B Consens, Ronald D Chervin, Robert A Koeppe, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive declineChristopher H Chapman, Vijaya Nagesh, Pia C Sundgren, et al.
Neuro-Oncology Practice|November 17, 2022
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphomaAnna M Laucis, Katherine Selwa, Yilun Sun, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium studyMichael D Prados, W K A Yung, Patrick Y Wen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 7, 2008
Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiformeIrwin H Lee, Morand Piert, Diana Gomez-Hassan, et al.
Journal of Neuro-Oncology|September 18, 2008
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05)Nicholas Butowski, Susan M Chang, Larry Junck, et al.
Scientific Reports|November 24, 2020
Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learningJoonsang Lee, Nicholas Wang, Sevcan Turk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastomaChristina I Tsien, Doris Brown, Daniel Normolle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade gliomaChristina Tsien, Craig J Galbán, Thomas L Chenevert, et al.
Pageof 9